Neurofeedback-Based Enhancement of Single Trial Auditory Evoked Potentials: Feasibility in Healthy Subjects.

Rieger, Kathryn; Rarra, Marie-Helene Margarete Philomena; Moor, Nicolas; Díaz Hernàndez, Laura; Bänninger, Anja; Razavi, Nadja; Dierks, Thomas; Hubl, Daniela; König, Thomas (2018). Neurofeedback-Based Enhancement of Single Trial Auditory Evoked Potentials: Feasibility in Healthy Subjects. Clinical EEG and neuroscience, 49(2), pp. 79-92. Sage 10.1177/1550059417708935

	Text EEG708935.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (643kB)
Preview	Text Preprint Neurofeedback based enhancement of single trial auditory evoked potentials Feasibility in healthy subjects.pdf - Accepted Version Available under License Publisher holds Copyright. Download (1MB) | Preview

Previous studies showed a global reduction of the event-related potential component N100 in patients with schizophrenia, a phenomenon that is even more pronounced during auditory verbal hallucinations. This reduction assumingly results from dysfunctional activation of the primary auditory cortex by inner speech, which reduces its responsiveness to external stimuli. With this study, we tested the feasibility of enhancing the responsiveness of the primary auditory cortex to external stimuli with an upregulation of the event-related potential component N100 in healthy control subjects. A total of 15 healthy subjects performed 8 double-sessions of EEG-neurofeedback training over 2 weeks. The results of the used linear mixed effect model showed a significant active learning effect within sessions ( t = 5.99, P < .001) against an unspecific habituation effect that lowered the N100 amplitude over time. Across sessions, a significant increase in the passive condition ( t = 2.42, P = .03), named as carry-over effect, was observed. Given that the carry-over effect is one of the ultimate aims of neurofeedback, it seems reasonable to apply this neurofeedback training protocol to influence the N100 amplitude in patients with schizophrenia. This intervention could provide an alternative treatment option for auditory verbal hallucinations in these patients.

Interest & Impact

Downloads

325 since deposited on 29 Dec 2017
29 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item